Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-45
Closed -$3.02K 510
2024
Q3
$3.02K Sell
45
-191
-81% -$15.7K ﹤0.01% 465
2024
Q2
$26.8K Sell
236
-348
-60% -$44K 0.01% 308
2024
Q1
$81K Sell
584
-24
-4% -$3.02K 0.04% 210
2023
Q4
$75.4K Sell
608
-1,757
-74% -$179K 0.04% 207
2023
Q3
$221K Buy
2,365
+901
+62% +$102K 0.13% 146
2023
Q2
$188K Buy
1,464
+253
+21% +$30.6K 0.11% 153
2023
Q1
$141K Buy
1,211
+345
+40% +$38.6K 0.09% 162
2022
Q4
$98.1K Buy
+866
New +$95.1K 0.06% 174
2021
Q1
Sell
-8
Closed -$1K 396
2020
Q4
$1K Buy
+8
New +$714 ﹤0.01% 406

Other funds holding DXCM

CNB Bank's DXCM Position: Q4 2024 in Review

CNB Bank sold out of DexCom (DXCM) in Q4 2024, closing a stake of 45 shares — an estimated $3.02K sold.

CNB Bank first reported a position in DXCM in Q4 2020 and held it in 9 quarters. The position peaked at $221K in Q3 2023. 951 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • CNB Bank reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • CNB Bank sold 45 DexCom shares in Q4 2024, an estimated $3.02K.
  • CNB Bank first reported a position in DexCom in Q4 2020 and held it in 9 quarters.
  • CNB Bank's DexCom position peaked at $221K in Q3 2023.
  • 951 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on CNB Bank's 13F filing for Q4 2024, filed 15 Jan 2025.